Paul Tudor Jones's PACB Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 684,707 shares of Pacific Biosciences of California, Inc. (PACB) worth $903,813, representing 0.00% of the portfolio. First purchased in 2015-Q1, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in PACB, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 684,707 shares. Largest reduction occurred in Q3 2022, reducing 493,119 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Pacific Biosciences of California (PACB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pacific Biosciences of California (PACB) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +684,707 | New Buy | 684,707 | $1.32 |
| Q4 2024 | -78,171 | Sold Out | 0 | $0.00 |
| Q3 2024 | +78,171 | New Buy | 78,171 | $1.70 |
| Q2 2024 | -291,569 | Sold Out | 0 | $0.00 |
| Q1 2024 | +291,569 | New Buy | 291,569 | $3.75 |
| Q1 2023 | -139,197 | Sold Out | 0 | $0.00 |
| Q4 2022 | +139,197 | New Buy | 139,197 | $0.01 |
| Q3 2022 | -493,119 | Sold Out | 0 | $0.00 |
| Q2 2022 | +493,119 | New Buy | 493,119 | $4.42 |
| Q1 2018 | -58,203 | Sold Out | 0 | $0.00 |
| Q4 2017 | +58,203 | New Buy | 58,203 | $2.65 |
| Q1 2017 | -78,879 | Sold Out | 0 | $0.00 |
| Q4 2016 | +78,879 | New Buy | 78,879 | $3.80 |
| Q3 2016 | -32,921 | Sold Out | 0 | $0.00 |
| Q2 2016 | +14,121 | Add 75.11% | 32,921 | $7.05 |
| Q1 2016 | +18,800 | New Buy | 18,800 | $8.51 |
| Q3 2015 | -30,400 | Sold Out | 0 | $0.00 |
| Q2 2015 | +4,700 | Add 18.29% | 30,400 | $5.76 |
| Q1 2015 | +25,700 | New Buy | 25,700 | $5.84 |
Paul Tudor Jones's Pacific Biosciences of California Investment FAQs
Paul Tudor Jones first purchased Pacific Biosciences of California, Inc. (PACB) in Q1 2015, acquiring 25,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Pacific Biosciences of California, Inc. (PACB) for 19 quarters since Q1 2015.
Paul Tudor Jones's largest addition to Pacific Biosciences of California, Inc. (PACB) was in Q1 2026, adding 684,707 shares worth $903,813.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 684,707 shares of Pacific Biosciences of California, Inc. (PACB), valued at approximately $903,813.
As of the Q1 2026 filing, Pacific Biosciences of California, Inc. (PACB) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Pacific Biosciences of California, Inc. (PACB) was 684,707 shares, as reported at the end of Q1 2026.